Amakem, NV Report issue

For profit Phase 2
Founded: Diepenbeek Belgium (2010)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
2012
NCT01693315
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now